News

FDA recall medical device recall product recall

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

heart drugs with stethoscope

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

passport visa foreign international travel

ACR and other medical societies recently wrote to the secretaries of State and Homeland Security to voice their concern about ongoing staffing issues. 

Lung cancer screening stethoscope

Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings. 

Economics

Legislative changes, demographic shifts and growing demand will combine to drive national health spending to almost $9 trillion by 2034.

Robotic chess

Pitting three multipurpose LLMs against two healthcare-specific AI tools, researchers have discovered the consumer-level AI can beat its purpose-built counterparts in healthcare scenarios—and soundly, at that. 

Thumbnail

The lawsuit dates back to 2019 but has been stuck in the court process for years. In the end, the health plan will pay Pomona Valley Hospital for emergency care delivered to patients at an out-of-network rate—though the facility didn’t get all of what it was seeking. 

Thumbnail

Researchers believe pigeons' perceptual processes could be used to develop artificial intelligence applications in radiology.

Thumbnail

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.

robot reviewing heart data

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

 Derek Pineda, FNP, CCRN, RCIS, FACC, with Mount Sinai Fuster Heart Hospital, explains the use of a digital app platform for STEMI team coordination that helped his health system improve STEMI outcomes.

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.

Around the web

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?